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The speciality of travel medicine, with its dual focus on
protecting the health of the individual and protecting the
wider community in which that individual lives, works or
travels, was born in 1988 when the First Conference on
International Travel Medicine was held in Zurich. Three
years later, in 1991, the International Society of Travel
Medicine (ISTM; http://www.istm.org) was formed at a
second conference in Atlanta. This year, CISTM11, the
11th conference of the ISTM, was held in Budapest,
attracting over 2000 participants from 65 countries around
the world. Initially derived from infectious diseases and
tropical medicine, the speciality now encompasses primary
care, migrant medicine, occupational medicine, wilderness
medicine, and international health.
Over the past decade, the global public health community
has been facing the challenges brought on by the emergence
and rapid worldwide spread of novel inﬂuenza virus strains,
severe acute respiratory syndrome virus, chikungunya virus,
and drug-resistant Mycobacterium tuberculosis, among other
pathogens. Modern transportation and the growth of tour-
ism, immigration and business travel were factors that con-
tributed to the dissemination of these high-impact pathogens.
In recent years, growth in international travel has been esti-
mated at approximately 6% per year, and similar trends are
expected in the future. Some 80 million individuals from
industrialized nations travel to the developing world each
year, and it is estimated that more than 200 million people
now reside outside their country of birth.
Travellers can spread new and re-emerging infectious dis-
eases that initially appear in developing countries, and can
act as ideal sentinels for the early detection of these dis-
eases. Specialized travel/tropical medicine clinics are ideally
situated to effectively detect emerging infections and to track
ongoing trends in travel-related illness. Travellers seen at rel-
atively few sentinel sites by such collaborative networks as
GeoSentinel <http://www.geosentinel.org>, TropNet Europe
and the recently born EuroTravNet provide a sample of dis-
ease agents in over 230 different countries. Over the past
decade, both global and regional provider-based surveillance
networks have emerged that have provided, for the ﬁrst
time, systematic and robust data that deﬁne the spectrum of
illness and the places of exposure to the most signiﬁcant
health risks that face travellers.
European travellers represent the vast majority of interna-
tional travellers, with Germany, the UK, France and Italy
being the leading countries of origin. In this context, the
ISTM has initiated EuroTravNet (http://www.eurotravnet.
eu)—the European Travel Medicine Network of the Euro-
pean Centre for Disease Prevention and Control—to create
a network of clinical experts in tropical and travel medicine
to support detection, veriﬁcation, assessment and communi-
cation of communicable diseases that can be associated with
travel and speciﬁcally with tropical diseases. The goal of
EuroTravNet is to build, maintain and strengthen a multi-
disciplinary network of highly qualiﬁed experts with demon-
strated competence in diseases of interest, ideally in the ﬁeld
of travel advice, tropical medicine, clinical diagnosis of the
returned traveller, and detection, identiﬁcation and manage-
ment of imported infections. In this special issue of Clinical
Microbiology and Infection, P. Schlagenhauf, F. Santos-O’
Connor and P. Parola, on behalf of EuroTravNet and the
European Centre for Disease Prevention and Control,
outline the current diversity and challenges facing travel
medicine practice in Europe and present ongoing, innovative
approaches to capture the status quo of travel medicine in
the European context.
Many purposes for travel exist, and each may uniquely
impact on the risk and characteristics of travel-associated
diseases. Tourism, immigration and business are the most
frequent reasons for travelling; however, other purposes,
such as missionary or volunteer work, study, healthcare-
seeking, visiting friends or relatives, pilgrimage, or military
missions, need to be considered. The very comprehensive
review by F. Pages, M. Faulde, E. Orlandi-Pradines and P. Pa-
rola of vector-borne diseases in military forces overseas illus-
trates the speciﬁc issues applicable to travel-related disease
risks in soldiers, and also demonstrates that military medi-
cine and travel medicine have many commonalities.
New trends in eco-tourism, including trekking in remote
areas of sub-Saharan Africa, expose tourist travellers to
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unusual parasitic diseases such as human African trypanoso-
miasis or acute schistosomiasis. Such diseases in non-immune
individuals are characterized by the difﬁculties of diagnosis
and therapeutic strategy, as illustrated by S. Jaureguibery,
L. Paris and E. Caumes in their review of Katayama fever in
travellers.
These three reviews provide an indication of the vitality
of travel medicine in Europe. The launch of EuroTravNet,
which aims to address travel-associated diseases globally, is a
great step towards the federation of travel medicine special-
ists within Europe. Its strong link and sharing of a database
platform with GeoSentinel, the worldwide surveillance net-
work of the ISTM, ensures its connection with the rest of
the world. Such initiatives are key to the credibility of the
discipline of travel medicine as an evidence-based medical
speciality.
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